Josi Holz

Josi Holz has over 20 years of experience in the medical field. In 2021, they began their current role as Chief Medical Officer at Prokarium. Prior to this, they held the same role at Synklino and STORM Therapeutics Limited from 2020. From 2015-2018, they were an Independent Business Owner at Josefin-Beate Holz "Bioneer-Consulting", and from 2018-2020 they were a Clinical Advisor at Calypso Biotech. From 2013-2015, they were the Vice President of LEO Project Management at LEO Pharma A/S, and from 2007-2013 they served as the Chief Medical Officer at Ablynx NV. From 2005-2007, they were the Vice President of Drug Development at U3 Pharma, and from 2004-2005 they were the Director of Clinical Trials and Safety at GPC Biotech. Josi began their career in 2001 as the Medical Director at Allos Therapeutics, Inc.

Josi Holz attended The Philipp University of Marburg from 1986 to 1991, where they obtained an MD in Medicine, Pharmacokinetics, and TOF Mass Spectorometry.